Feb 2, 2021 7:58 am EST NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition
Jan 6, 2021 11:00 pm EST NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Jan 5, 2021 4:05 pm EST NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
Jan 4, 2021 7:30 am EST NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference
Nov 13, 2020 4:05 pm EST NeoGenomics To Virtually Participate In Fireside Chat At The Stephens Annual Investment Conference 2020
Oct 27, 2020 7:00 am EDT NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter
Oct 13, 2020 9:00 am EDT NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China
Oct 1, 2020 7:00 am EDT NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020
Sep 10, 2020 4:05 pm EDT NeoGenomics To Virtually Participate In Fireside Chat At The 18th Annual Morgan Stanley Global Healthcare Conference
